Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Μaria Grammoustianou
Observed names:
Christina Paraskeva,
M. Grammoustianou,
Maria Grammoustianou
Institutions:
National and Kapodistrian University of Athens,
Sotiria General Hospital
Observed institutions:
Inserm,
National and Kapodistrian University of Athens,
Institut Gustave Roussy,
General Hospital of Athens G. Genimatas,
Sotiria General Hospital,
Alexander Fleming Biomedical Sciences Research Center
show all 6
ORCID:
0000-0002-3627-6290
Observed ORCID:
0000-0002-3627-6290
OpenAlex ID:
A5091109664
Malignant Superior Vena Cava Syndrome: State of the Art
2022
·
Vasileios Patriarcheas
, Maria Grammoustianou
, et al.
·
Cureus
·
54
PDF
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
2022
·
Ioannis P. Trontzas
, Ioannis Vathiotis
, et al.
·
Vaccines
·
14
PDF
Tackling healthcare providers bias: a systematic review of interventions with implications for inclusive clinical research
2025
·
Maria Grammoustianou
, Stefano Maccarone
, et al.
·
EClinicalMedicine
·
13
Current Status and Future Perspectives of Antibody–Drug Conjugates in Hormone Receptor-Positive Breast Cancer
2024
·
Maria Grammoustianou
, Foteinos-Ioannis Dimitrakopoulos
, et al.
·
Cancers
·
13
The Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lungs: Insights from the LANCE Pilot Study
2024
·
Georgios Evangelou
, Ioannis P. Trontzas
, et al.
·
Biomedicines
·
12
Real-world safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive/HER2-low metastatic breast cancer: a multicenter retrospective cohort study
2025
·
Elias Kotteas
, Εmmanouil Panagiotou
, et al.
·
Future Oncology
·
5
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study
2024
·
Marousa Kouvela
, Maria Effrosyni Livanou
, et al.
·
Cancers
·
3
PDF
Pulmonary Rehabilitation Modifies Functional Decline During First-Line Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer
2026
·
Christiana Lekka
, Nikolaos Chynkiamis
, et al.
·
CHEST Pulmonary
·
1
Thromboprophylaxis in lung cancer patients with tinzaparin: Results from the investigation on cancer & lung thromboprophylaxis—The iCaLTstudy.
2022
·
Marousa Kouvela
, Maria Grammoustianou
, et al.
·
Journal of Clinical Oncology
·
1
84P Effect of supervised exercise on functional capacity, quality of life, and treatment response in patients with advanced lung cancer receiving first-line immunotherapy
2026
·
C.P.T. Lekka
, N. Chynkiamis
, et al.
·
ESMO Open
Tackling healthcare provider bias in care and research: A systematic review.
2025
·
Maria Grammoustianou
, Stefano Maccarone
, et al.
·
Journal of Clinical Oncology
PDF
PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients
2022
·
M. Grammoustianou
, K.N. Syrigos
, et al.
·
Thrombosis Research
PO-40: Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC)
2022
·
E. Dimakakos
, M. Grammoustianou
, et al.
·
Thrombosis Research
PO-15: Tinzaparin: a safe choice for lung cancer with VTE and renal impairment
2022
·
E. Dimakakos
, K.N. Syrigos
, et al.
·
Thrombosis Research
189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer
2022
·
I.P. Trontzas
, I. Vathiotis
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
15
Citation count:
116
H-index:
5
I10-index:
5
Year
Topic
Type